Hyundai Oilbank IPO stuck amid faltering Korean ECM

Korea exchange 230-150x
By Jonathan Breen
04 Oct 2018

South Korea’s IPO market is struggling to gain momentum, buffeted by a drop in the benchmark equity index and an increase in surveillance of listing hopefuls by the financial regulator. With the market expected to remain fragile, caution appears to be the way to go, writes Jonathan Breen.

Korea’s Financial Services Commission (FSC) began ramping up its assessment of potential IPO issuers this year after an investigation into Samsung Biologics found that the company had failed to disclose key accounting information before its listing.

Admittedly, Samsung Biologics floated back in October 2016 for W2.25tr ($1.99bn) ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial